Povedano Pandés Mónica, Rojas García Ricard, Querol Gutiérrez Luis, Rodríguez de Rivera Francisco Javier, Colomer Font Carolina, Noé Sebastián Enrique, Navarro Pérez Mª Dolores, Juárez Belaunde Alan, Ferri Campos Joan, Guijarro Castro Teresa Cristina
Grupo de Estudio de Enfermedades Neuromusculares de la Sociedad Española de Neurología. Barcelona. España.
Sociedad Española de Neurorrehabilitación (SENR). España.
Rev Esp Salud Publica. 2025 Jun 18;99:e202506006.
Postpolio syndrome (PPS), which affects 20% to 50% of patients decades after initial poliovirus infection, poses a significant clinical challenge due to its unknown etiology and lack of pathogenic treatment. The main current theories point to degenerative processes secondary to the initial infection as the basis of its pathogenesis. Our guide addresses this complex landscape, providing a structured, evidence-based approach to the management of these sequelae. We emphasize the importance of: A personalized comprehensive evaluation; The development of multidisciplinary programs specifically designed to maximize functionality; Preventing complications and improving the quality of life of patients. We propose that these interventions be carried out under the supervision of an interdisciplinary team of specialists, who will use validated tools and personalized strategies based on the individual clinical characteristics of each patient. This approach ensures optimal functional benefit, aligned with current principles of evidence-based clinical practice.
小儿麻痹后遗症(PPS)在初次感染脊髓灰质炎病毒数十年后会影响20%至50%的患者,由于其病因不明且缺乏针对性治疗,构成了重大的临床挑战。目前的主要理论认为,继发于初次感染的退行性病变过程是其发病机制的基础。我们的指南阐述了这一复杂情况,提供了一种结构化的、基于证据的方法来管理这些后遗症。我们强调以下几点的重要性:个性化的全面评估;制定专门设计的多学科计划以最大限度地提高功能;预防并发症并改善患者的生活质量。我们建议这些干预措施在跨学科专家团队的监督下进行,该团队将根据每位患者的个体临床特征使用经过验证的工具和个性化策略。这种方法确保了最佳的功能效益,符合当前循证临床实践的原则。